Eyenuk raises $5.61M in late-stage round, disclosed via SEC Form D
What's the deal? Eyenuk, the AI diagnostics company, has raised $5.61 million in a late-stage venture round.
It disclosed the financing in a Form D filing with the Securities and Exchange Commission, against a total target of $5.65 million.
Why now? The Securities and Exchange Commission requires companies to file a Form D within 15 days of the first sale when raising capital through private placements under Regulation D.
The exemption lets companies tap investors without the cost and disclosure of a public offering.
What could go wrong? Compliance is key: Eyenuk must report all data accurately and amend the filing to reflect any material changes, or risk the offering's legal status.
The round also came in just shy of target, leaving roughly $40,000 unraised.
The signal: Eyenuk bills itself as a leader in autonomous AI eye screening for disease detection, and this breakout-stage company's modest top-up round signals continued investor appetite for AI-driven medical diagnostics even as broader venture funding stays cautious.
Read more: AInvest
Image credit: "09-8074-37" by NavyMedicine is marked with Public Domain Mark 1.0. To view the terms, visit https://creativecommons.org/publicdomain/mark/1.0/.
